We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Blood Marker Linked to Pancreatic Cancer

By LabMedica International staff writers
Posted on 08 Nov 2012
Print article
Pancreatic cancer risk has been linked to differences in the length of telomeres, which are the end caps on chromosomes in blood cells.

Telomeres maintain the stability of genes and shorten with age as cells divide. People of the same chronological age can have vastly different telomere lengths, meaning some people's cells can be viewed as biologically older than cells from other people the same age.

Scientists at the University of Wisconsin Carbone Cancer Center (Madison, WI, USA) took blood samples from more than 1,500 people, 499 of them with a diagnosis of pancreatic cancer and 963 of them cancer-free control subject at the Mayo Clinic (Rochester, MN, USA).


The scientists were interested in the length of the telomeres found in white blood cells and they found a direct relationship with the risk of pancreatic cancer. Telomere length was measured in peripheral blood leukocytes (PBLs) using quantitative real-time polymerase chain reaction (PCR) in the cases with pancreatic cancer and the cancer-free controls. The results were computed using logistic generalized additive models (GAM) adjusting for multiple variables.

The investigators observed a significant nonlinear association between telomere length in peripheral blood samples and the risk for pancreatic cancer. Risk was lower among those with longer telomeres compared with shorter telomeres across a range from the 1st percentile to 90th percentile of telomere length. There was also some evidence for higher risk among those with telomeres in the longest extreme. Shortened telomeres in the blood cells are known to be associated with other types of cancer, including colon cancer.

The authors concluded that short telomeres in peripheral blood are associated with an increased risk for pancreatic cancer across most of the distribution of length, but extremely long telomeres may also be associated with higher risk. Halcyon G. Skinner, PhD, MPH, the lead author, said, “We know that people with many factors that are classically unhealthy also tend to have shorter telomeres. Those who have had stressful lives, exposed to chronic inflammation, have poor glucose control or smoked cigarettes tend to have shorter telomeres, and that can set the stage for genetic damage.” The study was published on October 23, 2012, in the journal Cancer Epidemiology Biomarkers and Prevention.

Related Links:

University of Wisconsin Carbone Cancer Center


New
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Anti-Rubella IgG (Rubella IgG) Test
Rubella IgG AccuBind ELISA
New
Sexually Transmitted Diseases Test
STD Panel Strip

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.